dementia

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) surged more than 20 percent in Tuesday’s pre-market after it announced positive data from its Phase 2a study in mild-to-moderate Alzheimer’s patients. “At 41 weeks, Alzheimer’s patients taking a daily oral dose of ANAVEX 2-...

Finnish Biotech company Biotie Therapies (NASDAQ: BITI) (OTC: BIOZF) hopes to raise $56 million in its upcoming IPO this Friday, June 12. The company will offer 3.8 ADSs at price of $14.82, up 12 percent from its original offer. The deal was initially set for 3.4 million ADSs at the same price...